Transgene S.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 53110
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 37219
 
 
 
C07K PEPTIDES 21114
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 791
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 695
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 486
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 147
 
 
 
B01J CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 1110
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1192

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0157,188 ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORSJul 16, 15Jun 08, 17[C12N, A61K, C07K]
2017/0143,780 COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORSJul 16, 15May 25, 17[C12N, A61K, C07K]
2017/0145,392 HBV Polymerase MutantsDec 05, 16May 25, 17[C12N, C12P, A61K, C07K]
2017/0072,047 Composition for Treating HBV InfectionJul 06, 16Mar 16, 17[C12N, A61K]
2017/0002,081 ANTIBODY AGAINST THE CSF-1RJul 19, 16Jan 05, 17[C07K]
2016/0331,823 Fusion of Heterooligomeric Mycobacterial AntigensJan 09, 15Nov 17, 16[A61K, C07K]
2015/0250,869 VIRUS-CONTAINING FORMULATION AND USE THEREOFOct 02, 13Sep 10, 15[C12N, A61K]
2015/0165,014 Mycobacterial Antigen VaccineJul 10, 13Jun 18, 15[A61K, C07K]
2013/0287,737 Poxviral Oncolytic VectorsFeb 27, 13Oct 31, 13[A61K]
2012/0251,569 COMPOSITION FOR TREATING HBV INFECTIONMar 17, 12Oct 04, 12[C12N, A61P, A61K, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9687515 Poxviral oncolytic vectorsApr 10, 14Jun 27, 17[C12N, A61K]
9676859 In vitro generation of dendritic cells by exposure to an anti-CSF1-R antibodyNov 08, 13Jun 13, 17[C12N, C07K]
9512412 HBV polymerase mutantsJul 12, 12Dec 06, 16[C12N, A61K]
9428584 Antibody against the CSF-1RMay 17, 13Aug 30, 16[C12P, A61K, C07K]
9393299 Composition for treating HBV infectionAug 06, 10Jul 19, 16[A61K]
9295702 Process for producing poxviruses and poxvirus compositionsDec 23, 14Mar 29, 16[C12N, A61K, C07K]
9261512 Biomarker for treating cancer patientsJul 06, 10Feb 16, 16[A61K, G01N]
9221912 Antibody against the CSF-1RJul 01, 13Dec 29, 15[C07H, A61K, C07K]
9207231 Biomarker for selecting patients and related methodsSep 18, 13Dec 08, 15[G01N, A61K]
9180150 Poxviral oncolytic vectorsNov 17, 08Nov 10, 15[C12N, A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0141,039 Biomarker for Monitoring PatientsABANJan 08, 14May 22, 14[A61K]
2014/0023,686 SOLUBLE ICAM-1 AS BIOMARKER FOR PREDICTION OF THERAPEUTIC RESPONSEABANMay 23, 13Jan 23, 14[G01N]
8445270 Immortalized avian cell lines and use thereofExpiredMay 11, 10May 21, 13[C12N]
2013/0095,557 IMMORTALIZED AVIAN CELL LINESABANJun 29, 11Apr 18, 13[C12N]
8415462 Signaling peptidesExpiredJan 29, 08Apr 09, 13[C12N, C07H, C12P, C12Q]
2013/0039,891 POXVIRAL ONCOLYTIC VECTORSABANSep 15, 12Feb 14, 13[C12N, A61P, A61K]
8293528 Peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virusExpiredDec 17, 09Oct 23, 12[C12N, A48K]
8257692 Polypeptide having an improved cytosine deaminase activityExpiredJun 24, 10Sep 04, 12[A01N, A61K]
2012/0190,100 ENZYMATIC COMPOSITION FOR THE DIGESTION OF CHICKEN EMBRYOSABANJul 21, 10Jul 26, 12[C12N, C12S]
8226954 Polypeptide having an improved cytosine deaminase activityExpiredJun 24, 10Jul 24, 12[C07H, C12P, A61K, C07K]
8211444 Hepatitis C virus non structural fusion proteinExpiredMar 06, 07Jul 03, 12[C12N, N12N, A61K]
2012/0058,493 BIOMARKER FOR MONITORING PATIENTSABANApr 12, 10Mar 08, 12[G01N]
2012/0028,279 BIOMARKER FOR MONITORING PATIENTSABANMar 23, 10Feb 02, 12[G01N]
2011/0312,525 SOLUBLE ICAM-1 AS BIOMARKER FOR PREDICTION OF THERAPEUTIC RESPONSEABANJan 18, 10Dec 22, 11[C40B, G01N]
8080525 Peptide compositions and their use against the hepatitis C virusExpiredJun 03, 08Dec 20, 11[A61P, A61K, C07K]
8067228 Nucleic acid compositions and their use against the hepatitic C virusExpiredSep 16, 08Nov 29, 11[C12N, A61K]
2011/0287,089 USE OF A SACCHAROMYCES CEREVISIAE MITOCHONDRIAL NUCLEIC ACIDS FRACTION FOR IMMUNE STIMULATIONABANJan 08, 10Nov 24, 11[A61P, A61K]
7947288 Viral particles encoding multifunctional cytokinesExpiredApr 27, 09May 24, 11[C12N, A61K]
2011/0117,578 BIOMARKER FOR SELECTING PATIENTS AND RELATED METHODSABANMay 27, 09May 19, 11[C12Q, G01N]
7892828 Method of identifying a MHC class I restricted T cell responseExpiredOct 13, 09Feb 22, 11[C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.